KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Earnings History
Net Loss6 years of earnings data (2020–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Earnings Overview
As of June 22, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported trailing twelve-month net income of -$145M, reflecting -151.5% year-over-year growth. The company earned $-2.74 per diluted share over the past four quarters, with a net profit margin of -190.3%.
Looking at the long-term picture, KMTS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$29M in fiscal 2020.
KESTRA MEDICAL TECHNOLOGIES, LTD. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MDT ($4.61B net income, 13.9% margin), ABT ($13.98B net income, 31.9% margin), BSX ($2.89B net income, 14.4% margin), KMTS has room to improve margins relative to the peer group. Compare KMTS vs MDT →
KMTS Earnings vs Peers
Earnings metrics vs comparable public companies
KMTS Historical Earnings Data (2020–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$114M | -20.9% | -$106M | $-5.13 | -190.3% | -177.8% |
| 2024 | -$94M | -11.7% | -$85M | $-2.04 | -338.4% | -305.8% |
| 2023 | -$84M | -147.0% | -$80M | $-1.75 | -1104.0% | -1054.0% |
| 2021 | -$34M | -15.7% | -$33M | $-0.69 | - | - |
| 2020 | -$29M | - | -$29M | $-0.59 | - | - |
Download Data
Export KMTS earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
KMTS — Frequently Asked Questions
Quick answers to the most common questions about buying KMTS stock.
What is KMTS earnings per share (EPS)?
KMTS trailing twelve-month (TTM) diluted EPS is $-2.74, reflecting -151.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2025 is available in the table on this page.
What is KESTRA MEDICAL TECHNOLOGIES, LTD.'s net income?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) trailing twelve-month net income is $-145M as of 2025. Earnings declined -151.5% year-over-year.
Is KMTS profitable?
KMTS is not currently profitable on a TTM basis, reporting a net loss of $-145M. Net margin is -190.3%. Investors should monitor for a return to profitability.
What is KMTS's earnings growth rate?
KMTS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2025.
What are KMTS's profit margins?
KESTRA MEDICAL TECHNOLOGIES, LTD. net profit margin is -190.3%, operating margin is -177.8%, and gross margin is +40.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is -55.4%.
Is KMTS growing earnings?
KMTS earnings are declining — EPS fell -151.5% year-over-year. TTM net income dropped to $-145M. This contrasts with the 5-year CAGR of N/A.
What was KMTS's best earnings year?
KESTRA MEDICAL TECHNOLOGIES, LTD.'s highest annual net income on record is $-29M, achieved in fiscal year 2020. Earnings history on this page spans 2020 to 2025 and includes all annual and quarterly figures.
What were KMTS's earnings last quarter?
KMTS's most recent reported quarter was Q3 2026. Net income was $-34M with diluted EPS of $-0.61. For a full breakdown of all quarters, see the quarterly earnings table on this page.